Diphtheria toxin epitopes

An isolated and purified peptide comprising the amino acid sequence Val-His-His-Asn-Thr-Glu-Glu-Ile-Val-Ala-Gln-Ser-Ile-Ala-Leu-Ser-Ser-Leu-Me t-Val (SEQ ID NO:3), or an immunogenic fragment or subunit thereof, wherein the peptide consists of no more than about 40 amino acid residues.

An isolated and purified peptide comprising the amino acid sequence Gln-Ser-Ile-Ala-Leu-Ser-Ser-Leu-Met-Val-Ala-Gln-Ala-Ile-Pro-Leu-Val-Gly-Gl u-Leu (SEQ ID NO:4), or an immunogenic fragment or subunit thereof, wherein the peptide consists of no more than about 40 amino acid residues.

An isolated and purified peptide comprising the amino acid sequence Val-Asp-Ile-Gly-Phe-Ala-Ala-Tyr-Asn-Phe-Val-Glu-Ser-Ile-Ile-Asn-Leu-Phe-Gl n-Val-Val (SEQ ID NO:5), or an immunogenic fragment or subunit thereof, wherein the peptide consists of no more than about 40 amino acid residues.

An isolated and purified peptide comprising the amino acid sequence Gln-Gly-Glu-Ser-Gly-His-Asp-Ile-Lys-Ile-Thr-Ala-Glu-Asn-Thr-Pro-Leu-Pro-Il e-Ala (SEQ ID NO:6), or an immunogenic fragment or subunit thereof, wherein the peptide consists of no more than about 40 amino acid residues.

An isolated and purified peptide comprising the amino acid sequence Gly-Val-Leu-Leu-Pro-Thr-Ile-Pro-Gly-Lys-Leu-Asp-Val-Asn-Lys-Ser-Lys-Thr-Hi s-Ile (SEQ ID NO:7), or an immunogenic fragment or subunit thereof, wherein the peptide consists of no more than about 40 amino acid residues.

An isolated and purified peptide comprising an amino acid sequence homologous or identical to a portion of the amino acid sequence of diphtheria toxin, wherein the peptide has at least 7 and at most 40 amino acid residues, wherein a portion of the amino acid sequence in the peptide contains a contiguous sequence of amino acid residues that form at least a portion of one alpha helix or a beta sheet in vitro or in vivo, which peptide comprises an immunodominant region sequence.

A vaccine comprising an immunogenic amount of at least one diphtheria toxin-specific peptide containing an immunodominant region sequence, wherein the peptide is combined with a physiologically acceptable, non-toxic liquid vehicle, which amount is effective to immunize a susceptible mammal against Corynebacterium diphtheriae, wherein the peptide has at least 7 and at most 40 amino acid residues.

An immunogenic composition comprising a peptide linked to a non- or poorly immunogenic molecule, wherein the peptide comprises an amino acid sequence homologous or identical to a portion of the amino acid sequence of diphtheria toxin, wherein the peptide comprises an immunodominant region sequence, and wherein the peptide has at least 7 and at most 40 amino acid residues.

An immunogenic composition comprising a peptide linked to a non- or poorly immunogenic molecule, wherein the peptide comprises a contiguous amino acid sequence that is present on the surface of crystallized diphtheria toxin, wherein the peptide consists of no more than about 40 amino acid residues, and wherein the peptide comprises an immunodominant region sequence.